Ultrasensitive detection of total and phosphorylated Tau protein in human blood using SMC technology
MILLIPORESIGMA SPONSORED CONTENT

Ultrasensitive detection of total and phosphorylated Tau protein in human blood using SMC technology

Ultrasensitive detection of total and phosphorylated Tau protein in human blood using SMC technology

Tau protein is released from diseased and damaged neurons into cerebrospinal fluid as well as peripheral circulation (at lower levels) and is widely used to support the identification and qualification of Alzheimer’s Disease in association with other biomarkers or brain scans. Measuring this analyte at low abundance is vital to researchers, as it enables novel studies that address the role of this marker from health to disease, paving the way for future therapies aimed at slowing or even halting disease progression prior to late-stage symptoms. This poster illustrates the methods and results of a study showing how SMC® technology enables the accurate measurement of low-abundant biomarkers in biological samples. Download now to learn more.

Download Now

    Please fill out the information below to download the content. If you are already registered, or have requested a quote before, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

    • By submitting this form, you consent to Biocompare storing your email address and contact information and transmitting your contact information to the Future Lab sponsor. You also agree to receive email from Biocompare and the sponsor. You may request to be removed at any time.